A.D. Beadell Investment Counsel’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Buy
33,630
+3,895
+13% +$314K 1.68% 20
2026
Q1
$2.58M Buy
29,735
+700
+2% +$67.1K 1.64% 22
2025
Q4
$2.79K Buy
29,035
+290
+1% +$28.2K 1.81% 19
2025
Q3
$2.74M Sell
28,745
-500
-2% -$46K 1.86% 17
2025
Q2
$2.55M Buy
29,245
+250
+0.9% +$21.2K 1.94% 15
2025
Q1
$2.6M Sell
28,995
-1,000
-3% -$89.5K 2.17% 15
2024
Q4
$2.4M Sell
29,995
-490
-2% -$42.4K 1.94% 18
2024
Q3
$2.74M Sell
30,485
-1,925
-6% -$162K 2.19% 15
2024
Q2
$2.55M Buy
32,410
+360
+1% +$29.5K 2.13% 17
2024
Q1
$2.79M Buy
32,050
+2,285
+8% +$195K 2.44% 15
2023
Q4
$2.45M Sell
29,765
-650
-2% -$49.5K 2.34% 15
2023
Q3
$2.38M Sell
30,415
-125
-0.4% -$10.5K 2.49% 13
2023
Q2
$2.69M Sell
30,540
-565
-2% -$48.6K 2.6% 12
2023
Q1
$2.51M Buy
31,105
+893
+3% +$72.8K 2.29% 15
2022
Q4
$2.35M Sell
30,212
-3,225
-10% -$261K 2.04% 18
2022
Q3
$2.7M Buy
33,437
+25
+0.1% +$2.25K 2.43% 11
2022
Q2
$3M Sell
33,412
-1,578
-5% -$160K 2.49% 10
2022
Q1
$3.88M Buy
34,990
+450
+1% +$47.5K 2.57% 10
2021
Q4
$3.57M Buy
34,540
+1,145
+3% +$133K 2.23% 11
2021
Q3
$4.19M Sell
33,395
-135
-0.4% -$17.5K 2.72% 6
2021
Q2
$4.16M Sell
33,530
-630
-2% -$79.1K 2.63% 5
2021
Q1
$4.04M Sell
34,160
-500
-1% -$58.6K 2.72% 5
2020
Q4
$4.06M Hold
34,660
2.88% 7
2020
Q3
$3.6M Buy
34,660
+490
+1% +$49.2K 2.88% 6
2020
Q2
$3.13M Hold
34,170
2.77% 7
2020
Q1
$3.08M Buy
+34,170
New +$3.64M 3.33% 4

Other funds holding MDT

A.D. Beadell Investment Counsel's MDT Position: Q2 2026 in Review

A.D. Beadell Investment Counsel increased its Medtronic (MDT) stake by 13% in Q2 2026, buying an estimated $314K and bringing the position to 33,630 shares worth $2.63M. The position accounts for 1.68% of the portfolio, ranked #20.

A.D. Beadell Investment Counsel first reported a position in MDT in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.19M in Q3 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • A.D. Beadell Investment Counsel held 33,630 shares of Medtronic worth $2.63M as of Q2 2026.
  • A.D. Beadell Investment Counsel bought 3,895 Medtronic shares in Q2 2026, an estimated $314K.
  • Medtronic made up 1.68% of A.D. Beadell Investment Counsel's portfolio in Q2 2026, its #20 holding.
  • A.D. Beadell Investment Counsel first reported a position in Medtronic in Q1 2020 and has held it in 26 quarters since.
  • A.D. Beadell Investment Counsel's Medtronic position peaked at $4.19M in Q3 2021.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on A.D. Beadell Investment Counsel's 13F filing for Q2 2026, filed 15 Jul 2026.